2008
DOI: 10.1016/j.jneumeth.2007.08.021
|View full text |Cite
|
Sign up to set email alerts
|

A chronically implantable device for the controlled delivery of substances, and stimulation and recording of activity in severed nerves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…This also prevented axonal reinnervation of extraocular muscles or any other structure (Baker et al, 1981;DelgadoGarcía et al, 1988). This so-called intraorbitary device consisted of a chamber with two pieces of tubing inserted for the push-pull of fluid (Davis-Ló pez de Carrizosa et al, 2008). The chamber was made with a standard polypropylene pipette tip shortened to ϳ15 mm, thus giving it a conical shape.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This also prevented axonal reinnervation of extraocular muscles or any other structure (Baker et al, 1981;DelgadoGarcía et al, 1988). This so-called intraorbitary device consisted of a chamber with two pieces of tubing inserted for the push-pull of fluid (Davis-Ló pez de Carrizosa et al, 2008). The chamber was made with a standard polypropylene pipette tip shortened to ϳ15 mm, thus giving it a conical shape.…”
Section: Methodsmentioning
confidence: 99%
“…A possible role for NGF in regulating the morphophysiological characteristics of extraocular motoneurons and its afferent inputs has not yet been studied. To analyze this possibility, we induced alterations in the levels of NGF by either axotomy or externally applying NGF to the stump of the sectioned nerve (Davis-Ló pez de Carrizosa et al, 2008). Then, we examined the actions of NGF through its two receptors, neurotrophin receptor p75 (p75 NTR ) and TrkA.…”
Section: Introductionmentioning
confidence: 99%
“…For the delivery of neurotrophins, we implanted the stump of the abducens nerve in a custom-made chamber to control the milieu that bathed it and to prevent axonal reinnervation of any orbital structure or other extraocular muscles (Delgado-García et al, 1988). The intraorbitary device consisted of a chamber that had two pieces of tubing inserted for fluid replacement and two electrodes as we recently described (Davis-Ló pez de Carrizosa et al, 2008). The chamber was made with a standard polypropylene pipette tip shortened to ϳ15 mm and thus having conical shape.…”
Section: Methodsmentioning
confidence: 99%
“…It is well known that these changes in electrical and synaptic properties revert with target reinnervation (DelgadoGarcía et al, 1988;Brännström and Kellerth, 1999) and remain altered when reinnervation is prevented (Sumner, 1976;Pinter and Vanden Noven, 1989;Vanden Noven and Pinter, 1989). Thus, for preventing random target reinnervation and/or reestablishment of trophic support from orbital tissues, we devised a method for controlling the extracellular environment that bathes the axonal stumps (Davis-Ló pez de Carrizosa et al, 2008). We cannot ascertain whether neurotrophins signaled to afferents through transsynaptic translocation, like tetanus toxin does (González-Forero et al, 2005;Rind et al, 2005), or induced in the motoneurons the signal for alterations in their synaptic coverage.…”
Section: Alterations Of Target-derived Trophic Support Determine the mentioning
confidence: 99%
“…In a first set of experiments, we injected either BDNF, or NT-3, or a combination of both neurotrophins, to the distal stumps of sectioned axons, following two different experimental paradigms: in the first one, we administered the neurotrophin immediately following axotomy, to test the maintenance of motoneuron properties; in the second one, we first axotomized motoneurons and then checked whether neurotrophins could revert the effects of the lesion. To prevent lesioned motoneurons to establish contacts with new targets, we developed an administration device for chronic neurotrophin delivery, which allowed controlling the extracellular environment that bathes the axonal stumps [135]. In a second set of experiments, we injected NGF following the same paradigms explained above.…”
Section: Bdnf and Nt-3 Exert Complementary Actions On The Dischargmentioning
confidence: 99%